Iceland review - 2014, Qupperneq 53

Iceland review - 2014, Qupperneq 53
ICELAND REVIEW 51 Westfjords town of Ísafjörður (population 2,600). Guðmundur’s roots are in the town; although he points out that he hasn’t lived there for several years. “it is great to be able to create job oppor- tunities there for people with university degrees. in small places around iceland, they are few and far between.” The first product kerecis put on the market was MariGen omega3 Wound. it is already available in iceland, the uk and several Middle eastern markets. Guðmundur explains that originally, gauze fabric dressing was the only available option but 20-30 years ago, foam dressing took its place. “We focus on third generation healing products: biological materials made from animal tissue. This is an immensely valuable market seg- ment, with a turnover of almost a billion dollars per year. When founding the company we began searching for a suitable local ingredient and found out that no one had thought of using fish skin for tissue reconstruction—so we proceeded to rapidly cre- ate prototypes and secure patents in many countries, including the united States. Actually we have filed patents in 56 countries around the world.” FisH skin HAs MAjor AdvAntAges When kerecis was founded, third generation healing products were principally made from pig’s intestines and bladders, specially bred for that use. The company’s ingenious use of fish skin had many advantages. “First of all, the fish we use is both kosher and halal compatible, which eliminates cultural and religious con- straints to usage. This allows us to operate in one of our biggest target markets, the Middle east. Secondly, our product is the world’s only wound healing device that contains omega-3, which is only found in fish. omega-3 has various health benefits and is known to reduce or eliminate inflammation in damaged tissue. Thirdly, our product has a much lower risk of disease transfer than its porcine-derived counterparts. numerous viruses can be transmitted from pigs to other mammals whereas none can be transmitted from fish to humans. Moreover, our product is made from inexpensive material, locally sourced and fresh from the north Atlantic ocean. We begin processing it immediately after it has been filleted and de-skinned for food production. Therefore no antibiotics are required, which is not the case with pigs, which are swarming with bacteria upon slaughter. in addition, fish skin is a sturdier material and has been proven to encourage faster human cell re-growth as well as blood vein creation.” currently, the company is finishing development and patent applications of similar products intended for hernia repair, breast reconstruction and repair of the dura, the thick membrane that is the outermost of the three layers of the meninges that surround the brain and spinal cord, areas in which the demand for treat- ment methods is also increasing. in addition to the healing strips, kerecis has developed and marketed a successful skin care range called Maricell. “using our patented methods, we extract omega-3 oil from the fish skin and use it in four kinds of creams sold in icelandic pharmacies, targeted for: very dry skin, eczema, psoriasis, and skin problems relating to ingrown hair. They have been available for a year now and have been very well received. Although we do not see our- selves in the cosmetics market we might consider collaborating with skin care companies on products using our omega3 tech- nology. our focus will remain on problem skin.” iceLAnd A FAvorABLe Business environMent There has never been a question in Guðmundur’s mind that kerecis will be a success. “This is the fourth project that the founding team has worked on together and we all have exten- sive experience. in all those projects we went through the pro- cess of creating a new medical device, from idea to marketing. Therefore, there have been no major surprises or obstacles. it goes without saying that the more experience you have, the more likely you are to succeed,” says Guðmundur, adding that iceland provides a favorable environment for start-up businesses. “We have enjoyed great collaboration with the national Bioethics committee, the icelandic Medicines Agency and The national university Hospital. Furthermore, we have received substantial funding from the Technology development Fund, for which we are very grateful. The icelandic tax system is also encouraging: research and development costs are partially refunded, which helps a start-up get on its feet. on the other hand, research grants are relatively low here and there are not that many venture capitalists. i consider that we have also been quite successful with investors. We recently finished our third seed round, with fewer investors getting in than wanted.” For kerecis, the current focus is on establishing global dis- tribution of the chronic wound product Maricell omega3 Wound. parallel to that they will continue to develop the hernia repair, dura-repair and breast reconstruction products. “MariGen omega3 Wound has already been tested on 200 patients with great results; in addition to our existing markets in iceland, the uk and the Middle east, we have acquired marketing licenses in u.S. and some european countries. The constant worldwide growth in diabetes and other lifestyle-related illnesses is obvious- ly a tragic matter. But from a business point of view, it is great to be in a growing market. if you present a new solution to a prob- lem, everybody wants to try it. Also, you’re not taking anyone’s market share. The cake is growing and you get your piece without fighting other companies for it. Since a gram of our patented fish skin is worth more than gold, this could be an extremely lucra- tive enterprise if we play our cards right,” he says. “But the most important thing: taking one step at a time.” * innovation
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100

x

Iceland review

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Iceland review
https://timarit.is/publication/1842

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.